SOURCE: Research and Markets

Research and Markets

March 02, 2016 06:54 ET

Global Diabetic Care Market Analysis 2015 - 2022

Market to Grow Over $120+ Billion by 2022 With Type 2 Holding the Maximum Market Share

DUBLIN, IRELAND--(Marketwired - March 02, 2016) - Research and Markets has announced the addition of the "Global Diabetic Care Market Analysis, 2015 - 2022" report to their offering.

This study includes an overview and analysis of the Diabetic Care market, by type of diabetes, ecosystem (drug manufacturers, device manufacturers and mobile application developers), end-use applications, and geographical regions, allowing the research to develop a comprehensive outlook of the market.

The Diabetic Care market report presents a detailed and investigative study of the entire Diabetic Care ecosystem and provides a comprehensive insight into various forms of developments, trends and key participants. The different type of diabetes are categorized into three major categories, viz. type 1, type 2, and gestational, among others, in the report.

Type 2 diabetes is holding the maximum market share and is expected to grow at 9.16% CAGR from 2015 to 2022. The other type of diabetes includes Type 1 diabetes, and gestational diabetes. Observing current trends, gestational diabetes segment is expected to grow at a high CAGR of 11.13% from 2015 to 2022. The gestational diabetes cases are increasing since in this disease, during pregnancy, the insulin hormone secretion gets misbalanced.

Drug manufacturers were holding a market share of 66% in 2014 of the entire Diabetic Care market. The other segments of ecosystem include Device manufacturers and Mobile application developers. Observing the current pattern of trends, Healthcare ITs/Big Data companies are collaborating and entering into partnerships with healthcare providers, academic institutions, pharmaceuticals, and biotechnology companies to support the growth of the Diabetic Care market.

The global Diabetic Care market on the basis of end-use applications is classified into: patient monitoring, diagnosis, treatment, healthcare management, education & awareness, and prevention & wellness, among others. At present, patient monitoring is dominating the market and is expected to reach $24.03 billion by 2022, mostly since this application helps them to monitor the patient's health and activity by using medical or wearable devices that are connected with mobile Health apps.

Key Topics Covered:

1 Report Overview

2 Executive Summary

3 Market Overview

4 Market Dynamics

5 Competitive Insights

6 Industry Analysis

7 Global Diabetic Care Market By Diabetes Types

8 Global Diabetic Care Market By Ecosystem Players

9 Global Diabetic Care Market By Drug Types

10 Global Diabetic Care Market By Device Types

11 Global Diabetic Care Market By Mobile Application Developers

12 Global Diabetic Care Market By End-Use Application

13 Global Diabetic Care Market By Geography

14 Global Diabetic Care Market Key Players

Companies Mentioned:

  • AT&T, Inc.
  • Abbott Laboratories
  • Agamatrix, Inc.
  • AstraZeneca
  • Bayer Healthcare Ag
  • Boehringer Ingelheim Group
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • Glaxosmithkline Plc (GSK)
  • Johnson & Johnson
  • Medtronic Incorporation
  • Merck & Co., Inc
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche Diagnostics
  • Sanofi Pharma
  • Takeda Pharmaceutical Company Limited

For more information visit

Sector: Healthcare and Medical Devices

Image Available:

Contact Information

  • Research and Markets
    Laura Wood
    Senior Manager

    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716